Acute myocardial infarction during regadenoson myocardial perfusion imaging

Pharmacotherapy

Volumn 33, Issue 6, 2013, Pages

  Shah, Sachil ^a,c   Parra, David ^b,c   Rosenstein, Robert S ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adverse effects; Myocardial infarction; Myocardial perfusion imaging; Regadenoson

Indexed keywords

GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; REGADENOSON; TROPONIN I;

ACUTE HEART INFARCTION; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STEAL SYNDROME; DYSLIPIDEMIA; ELECTROCARDIOGRAM; HEART MUSCLE NECROSIS; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MYOCARDIAL PERFUSION IMAGING; PATIENT MONITORING; PHARMACOLOGIC STRESS TESTING; PROTEIN BLOOD LEVEL; RETROSTERNAL PAIN; SINUS BRADYCARDIA; ST SEGMENT ELEVATION; THORAX PAIN;

ADENOSINE A2 RECEPTOR AGONISTS; AGED; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; EXERCISE TEST; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; PURINES; PYRAZOLES;

EID: 84879576557     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1238     Document Type: Article

References (20)

1. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registry. J Am Coll Cardiol 1994;23:384-389.
2. Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. Circulation 1990;81:1205-1209.
3. Lette J, Tatum JL, Fraser S, et al. Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study. J Nucl Cardiol 1995;2:3-17.
4. Gao Z, Li Z, Baker SP, et al. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther 2001;298:209-218.
5. Johnson SG, Peters S. Advances in pharmacologic stress agents: focus on regadenoson. J Nucl Med Technol 2010;38: 163-171.
6. Astellas, Inc. Lexiscan package insert. Deerfield, IL; 2012.
7. Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007;14:645-658.
8. Kwon DH, Cerqueira MD, Young R, et al. Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patients. J Nucl Cardiol 2010;17:853-857.
9. Polad JE, Wilson LM. Myocardial infarction during adenosine stress test. Heart 2002;87:E2.
10. Raza JA, Khan NU, Mustafa JS, Movahed A. ST segment elevation during adenosine pharmacological stress testing in a patient with coronary artery disease. Am Heart Hosp J 2009;7: E122-E124.
11. Reyes E, Wechalekar K, Loong CY, Underwood SR. Acute myocardial infarction during adenosine myocardial perfusion imaging. J Nucl Cardiol 2004;11:97-99.
12. Lewen MK, Labovitz AJ, Kern MJ, Chaitman BR. Prolonged myocardial ischemia after intravenous dipyridamole thallium imaging. Chest 1987;92:1102-1104.
13. Kwai AH, Jacobson AF, McIntyre KM, Williams WH, Tow DE. Persistent chest pain following oral dipyridamole for thallium 201 myocardial imaging. Eur J Nucl Med 1990;16: 745-746.
14. Hansen CL, Williams E. Severe transmural myocardial ischemia after dipyridamole administration implicating coronary steal. Clin Cardiol 1998;21:293-296.
15. Safi AM, Pillai N, Rachko M, Chaudhry K, Stein RA. Dipyridamole-induced ST-segment elevation indicative of transmural myocardial ischemia-a case report. Angiology 2001;52:553-557.
16. Wichmann J, Loser R, Diemer HP, Lochner W. Pharmacological alterations of coronary collateral circulation; implication to the steal-phenomenon. Pflugers Arch 1978;373:219-224.
17. Becker LC. Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 1978;57: 1103-1110.
18. Granato JE, Watson DD, Belardinelli L, Cannon JM, Beller GA. Effects of dipyridamole and aminophylline on hemodynamics, regional myocardial blood flow and thallium-201 washout in the setting of a critical coronary stenosis. J Am Coll Cardiol 1990;16:1760-1770.
19. Sato A, Terata K, Miura H, et al. Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Am J Physiol Heart Circ Physiol 2005;288: H1633-640.
20. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.